- Clinical Expertise
- Research Faculty
- Molecular Carcinogenics
- Board Certifications
- Internal Medicine
- Appointments
- Frode Jensen Professor of Medicine; Professor of Public Health, Columbia University Medical Center
- Professor of Genetics & Development, Columbia University Medical Center
- Education
- B.S., 1952, University of Wisconsin, Madison, WI
- M.D., 1955, University of Wisconsin, Madison, WI
- Internship & Residency
- Internal Medicine, 1957, Montefiore Medical Center, New York, NY
- Metabolism Service, 1959, National Cancer Institute, New York, NY
- Fellowship
- Research Fellow, 1960, Harvard Medical School, Boston, MA
I. Bernard Weinstein, M.D.
TEL (212) 305-6921
FAX (212) 305-6889
- PROFILE SUMMARY
- I. Bernard Weinstein was born in Madison, Wisconsin. He received his Bachelor of Science and M.D. degrees from the University of Wisconsin and did clinical training in Internal Medicine and Oncology at Montefiore Hospital in New York. He then obtained training in clinical and laboratory research at the National Cancer Institute, Harvard Medical School and MIT. In 1961 he was recruited to the College of Physicians and Surgeons of Columbia University, where he has pursued his career in teaching and research to the present time. He is currently the Frode Jensen Professor of Medicine and holds joint appointments as Professor of Genetics and Development and Professor of Public Health. He is also an Attending Physician at the Presbyterian Hospital.
From 1985-1995 he was the Director of the Comprehensive Cancer Center of Columbia University. Under his leadership the Cancer Center developed outstanding programs in basic cancer research, clinical research, and cancer prevention. He is widely recognized for his contributions to our understanding of the molecular mechanisms of multistage carcinogenesis and their relevance to novel strategies for cancer prevention and therapy. His research findings are documented in over 600 scientific publications. He is a founder of the field of molecular epidemiology, a new approach to discovering the causes of specific human cancers. His recent concept of “oncogene addiction” provides a rationale for molecular targeting in cancer therapy.
His accomplishments have been recognized by his appointment to several national and international advisory committees and he has also received several honorary awards. In 1987 he received the Clowes Award from the American Association for Cancer Research (AACR) and in 1991 he served as President of the (AACR), the world’s largest basic and clinical cancer research organization. In 1992 he received an honorary degree from the University of Wisconsin, in recognition of his contributions to cancer research. He is a Member of the Institute of Medicine of the U.S. National Academy of Sciences, a Member of the American Association of Physicians, a Fellow of the American Academy of Arts and Sciences and a Fellow of the National Foundation for Caner Research. In 1999 he received the international Anthony Dipple Award for Carcinogenesis Research. In 2001 he received a Distinguished Award from the American Society of Cancer Prevention and an Award for Research Excellence in Cancer Epidemiology and Prevention that is jointly sponsored by the AACR and the American Cancer Society. In 2004 he received the Charles Heidelberger Award for Cancer Research.